Ignite Creation Date:
2024-05-06 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 2:14 PM
Study NCT ID:
NCT05054751
Status:
COMPLETED
Last Update Posted:
2022-06-13
First Post:
2021-08-13
Brief Title:
GB491 Combined With Fulvestrant for HR HER2- Locally Advanced or Metastatic Breast Cancer
Sponsor:
Genor Biopharma Co Ltd
Organization:
Genor Biopharma Co Ltd
Organization Data
Organization:
Genor Biopharma Co Ltd
Class:
INDUSTRY
Study ID:
GB491-004
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genor Biopharma Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None